Manav Bio Chem Impex Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 03-01-2025
- Paid Up Capital ₹ 1.22 Cr
as on 03-01-2025
- Company Age 19 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.25 Cr
as on 03-01-2025
- Revenue 16.04%
(FY 2023)
- Profit -11.22%
(FY 2023)
- Ebitda -22.98%
(FY 2023)
- Net Worth 18.24%
(FY 2023)
- Total Assets -4.59%
(FY 2023)
About Manav Bio Chem Impex
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.22 Cr.
The company has closed loans amounting to ₹8.25 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mukesh Shah and Fenil Shah serve as directors at the Company.
- CIN/LLPIN
U51496MH2005PTC153120
- Company No.
153120
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 May 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Manav Bio Chem Impex Private Limited offer?
Manav Bio Chem Impex Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Metal Oxides, Pharma Ingredients & Raw Materials, Anti Infective API, Organic and Inorganic Solvents, Aromatic Hydrocarbon Solvent, Industrial Chemicals & Supplies, Aroma Chemicals, Cooling Tower Corrosion Inhibitor, Liquid Phenol.
Who are the key members and board of directors at Manav Bio Chem Impex?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mukesh Shah  | Director | 19-May-2005 | Current |
| Fenil Shah | Director | 03-May-2022 | Current |
Financial Performance of Manav Bio Chem Impex.
Manav Bio Chem Impex Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.04% increase. The company also saw a substantial fall in profitability, with a 11.22% decrease in profit. The company's net worth Soared by an impressive increase of 18.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manav Bio Chem Impex?
In 2023, Manav Bio Chem Impex had a promoter holding of 73.20% and a public holding of 26.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 10 Apr 2006 | ₹2.50 M | Satisfied |
Union Bank Of India Creation Date: 10 Apr 2006 | ₹2.50 M | Satisfied |
Union Bank Of India Creation Date: 10 Apr 2006 | ₹7.00 Cr | Satisfied |
How Many Employees Work at Manav Bio Chem Impex?
Unlock and access historical data on people associated with Manav Bio Chem Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manav Bio Chem Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manav Bio Chem Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
